Polymorphisms in Human Muscarinic Receptor Subtype GenesMICHEL, Martin C; TEITSMA, Christine A.Handbook of experimental pharmacology. 2012, Vol 208, pp 49-59, issn 0171-2004, 11 p.Article

Overview of Muscarinic Receptor SubtypesEGLEN, Richard M.Handbook of experimental pharmacology. 2012, Vol 208, pp 3-28, issn 0171-2004, 26 p.Article

Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): mediation of separate responses by high affinity and low affinity agonist-receptor conformationsMCKINNEY, M; STENSTROM, S; RICHELSON, E et al.Molecular pharmacology. 1985, Vol 27, Num 2, pp 223-235, issn 0026-895XArticle

Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileumRINGDAHL, B.The Journal of pharmacology and experimental therapeutics. 1985, Vol 232, Num 1, pp 67-73, issn 0022-3565Article

The binding of a 2-chloroethylamine derivative of oxotremozine (BM 123) to muscarinic receptors in the rat cerebral cortexEHLERT, F. J; JENDEN, D. J.Molecular pharmacology. 1985, Vol 28, Num 2, pp 107-119, issn 0026-895XArticle

Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypesLEE, N. H; EL-FAKAHANY, E. E.The Journal of pharmacology and experimental therapeutics. 1991, Vol 256, Num 2, pp 468-479, issn 0022-3565, 12 p.Article

Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexusKILBINGER, H; NAFZIGER, M.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 328, Num 3, pp 304-309, issn 0028-1298Article

BLOCKADE OF DIFFERENT MUSCARINIC RECEPTOR SUBTYPES CHANGES THE EQUILIBRIUM BETWEEN EXCITATION AND INHIBITION IN RAT VISUAL CORTEXAMAR, M; LUCAS-MEUNIER, E; BAUX, G et al.Neuroscience. 2010, Vol 169, Num 4, pp 1610-1620, issn 0306-4522, 11 p.Article

Muscarinic Receptor Agonists and Antagonists: Effects on Cardiovascular FunctionHARVEY, Robert D.Handbook of experimental pharmacology. 2012, Vol 208, pp 299-316, issn 0171-2004, 18 p.Article

Muscarinic cholinergic receptor subtypes expression by human placentaSEYED KHOSROW TAYEBATI; SABBATINI, M; ZACCHEO, D et al.Neuroscience letters. 1997, Vol 221, Num 2-3, pp 208-212, issn 0304-3940Article

Rat lymphocytes release a factor which inhibits muscarinic ligand bindingMASLINSKI, W; RYZEWSKI, J; BARTFAI, T et al.Journal of neuroimmunology. 1988, Vol 17, Num 4, pp 275-285, issn 0165-5728Article

Functional roles of muscarinic M₂ and M₃ receptors in mouse stomach motility : Studies with muscarinic receptor knockout miceKITAZAWA, Takio; HASHIBA, Kano; JINSHAN CAO et al.European journal of pharmacology. 2007, Vol 554, Num 2-3, pp 212-222, issn 0014-2999, 11 p.Article

An HPLC method for determination of atropine in human plasmaSHAOYOUG LI; WAHBA KHALIL, S. K.Journal of liquid chromatography. 1990, Vol 13, Num 7, pp 1339-1350, issn 0148-3919Article

Muscarinic receptors and receptor-mediated actions on rat thymocytesMASLINSKI, W; KULLBERG, M; NORDSTROM, O et al.Journal of neuroimmunology. 1988, Vol 17, Num 4, pp 265-274, issn 0165-5728Article

Studies on muscarinic binding sites in human brain identified with [³H]pirenzepineSIONG-CHI LIN; OLSON, K. C; OKAZAKI, H et al.Journal of neurochemistry. 1986, Vol 46, Num 1, pp 274-279, issn 0022-3042Article

Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM₁ muscarinic acetylcholine receptorMELANCON, Bruce J; GOGLIOTTI, Rocco D; MORRISON, Ryan D et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 10, pp 3467-3472, issn 0960-894X, 6 p.Article

Development of novel M₁ antagonist scaffolds through the continued optimization of the MLPCN probe ML012MELANCON, Bruce J; UTLEY, Thomas J; JEFFREY CONN, P et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 15, pp 5035-5040, issn 0960-894X, 6 p.Article

Long-term wash-resistant effects of brief interaction of xanomeline at the M₁ muscarinic receptorDE LORME, Kayla C; SIKORSKI, Krista L; GRANT, Marianne K. O et al.Neuroscience letters. 2006, Vol 410, Num 1, pp 11-14, issn 0304-3940, 4 p.Article

Conformational analysis and receptor modelling of m1 and m2 selective antagonistsKERCKHOFF, H; HÖLTJE, H.-D.Pharmazie. 1994, Vol 49, Num 8, pp 566-573, issn 0031-7144Article

Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptorBARBIER, P; COLELLI, A; BOLOGNESI, M. L et al.European journal of pharmacology. 1998, Vol 355, Num 2-3, pp 267-274, issn 0014-2999Article

Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate: different ligand-receptor conformations versus different receptor subclassesSCHREIBER, G; SOKOLOVSKY, M.Molecular pharmacology. 1985, Vol 27, Num 1, pp 27-31, issn 0026-895XArticle

Structural correlates for down-regulation of m1 and m2 muscarinic receptor subtypesMALATYNSKA, E; WAITE, S; WEI, H.-B et al.Brain research bulletin. 1998, Vol 47, Num 3, pp 285-290, issn 0361-9230Article

Otenzepad shows two populations of binding sites in human gastric smooth muscleBELLIDO, I; FERNANDEZ, J. L; GOMEZ, A et al.Canadian journal of physiology and pharmacology. 1995, Vol 73, Num 1, pp 124-129, issn 0008-4212Article

Differential selectivity of M1 and M3 type muscarinic acetylcholine receptors in coupling with a G protein Go1α examined in Xenopus oocytesFUJII, K; KASAHARA, J; NAKAMURA, K et al.Neuroscience letters. 1996, Vol 215, Num 2, pp 131-133, issn 0304-3940Article

Pharmacological basis for functional selectivity of partial muscarinic receptor agonistsHELDMAN, E; BARG, J; FISHER, A et al.European journal of pharmacology. 1996, Vol 297, Num 3, pp 283-291, issn 0014-2999Article